git-1,
pix-1 and
pak-1 are the orthologs of human GIT (G protein-coupled receptor kinase interactor), PIX (Pak1-interacting exchange factor) and PAK (
p21 activated kinase). GIT1 is a GAP (GTPase-activating protein) for the Arf GTPases. PIX is a GEF (guanine-nucleotide exchange factor) for the Rho GTPases Rac and Cdc42 and PAK an effector of these later GTPases. These proteins form a complex shown to control morphology and migration of neuronal and non-neuronal cells in vertebrates mainly through regulation of membrane trafficking, focal adhesion dynamics and actin-myosin-mediated contraction. In C. elegans, GIT/PIX/PAK complex together with the integrins were shown to control cell shape and migration of distal tip cells during gonad morphogenesis. We demonstrate here that
git-1,
pix-1 and
pak-1 control early elongation events during C. elegans embryonic development. Early elongation involves machineries controlling the phosphorylation of the myosin-light chain (MLC),
mlc-4, and consequently the contraction of the actin-myosin contractile apparatus (AMCA). The Rho-binding kinase
let-502 was shown to promote AMCA contraction through inhibition of the MLC phosphatase activity of
mel-11 in lateral epidermal seam cells.
let-502/mel-11 elongation pathway was shown to act redundantly with a unknown pathway involving a MLC kinase activity. Interestingly, this parallel pathway involves
fem-2, a serine-threonine phosphatase whose closer homolog in mammals PP2c is known to control PAK activity downstream of PIX. Using loss-of function and dominant negative alleles of
pix-1,
git-1 and
pak-1, RNAi treatment, specific chemical inhibitors of MLC phosphorylation regulators and 4D-imaging we showed that reduction or suppression of GIT/PIX/PAK function results to similar elongation defects than observed in
let-502 loss-of-function mutants. We also showed that
git-1,
pix-1 and
pak-1 are antagonizing MLC dephosphorylation during elongation. Preliminary data suggest that this function of GIT/PIX/PAK during elongation would involve integrins. We are currently investigating whether this novel pathway acts in parallel to
mel-11 and
let-502 and if it involves
fem-2.